Cyber Media Research & Services IPO Details: Price, Dates & Financials
The Cyber Media Research & Services IPO is a closed SME Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 27 September 2022. The Cyber Media Research & Services IPO closed on 29 September 2022, with an issue price of ₹180 per share. The Cyber Media Research & Services IPO has a face value of ₹10 and a lot size of 800 shares. The Cyber Media Research & Services IPO is listed on 10 October 2022. The Cyber Media Research & Services IPO allotment was scheduled for 4 October 2022.
On the financial front, the Cyber Media Research & Services IPO reported revenue of ₹3,870 for 31-Mar-19, compared with ₹3,048 for 31-Mar-20. The Cyber Media Research & Services IPO PAT was ₹27 against ₹8. The Cyber Media Research & Services IPO net worth as of 31-Mar-19 was ₹171.
Always verify The Cyber Media Research & Services IPO details and GMP data with the official offer document before investing in the Cyber Media Research & Services IPO.
Financial Summary
Amount in Lakhs
Metric
31-Mar-19
31-Mar-20
31-Mar-21
Total Assets
1,630
1,708
1,700
Revenue
3,870
3,048
3,016
PAT
27
8
66
Net Worth
171
176
220
Cyber Media Research & Services IPO Financials FAQs
Revenue of Cyber Media Research & Services (Amount in Lakhs) — 31-Mar-19: 3,870; 31-Mar-20: 3,048; 31-Mar-21: 3,016. Profit after tax (PAT) — 31-Mar-19: 27; 31-Mar-20: 8; 31-Mar-21: 66.
Total assets — 31-Mar-19: 1,630; 31-Mar-20: 1,708; 31-Mar-21: 1,700. Net worth — 31-Mar-19: 171; 31-Mar-20: 176; 31-Mar-21: 220. (Amount in Lakhs)
The financials shown for Cyber Media Research & Services IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.